ArticleThe Lancet. Oncology2020

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.

Seth E Karol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.